Julie Alejo

676 total citations
5 papers, 188 citations indexed

About

Julie Alejo is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Julie Alejo has authored 5 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Julie Alejo's work include Immune Cell Function and Interaction (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Pregnancy and preeclampsia studies (1 paper). Julie Alejo is often cited by papers focused on Immune Cell Function and Interaction (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Pregnancy and preeclampsia studies (1 paper). Julie Alejo collaborates with scholars based in United States, Spain and Italy. Julie Alejo's co-authors include Stefania Pittaluga, Keiko Sakamoto, Helena B. Pasieka, Jon H. Meyerle, Jay‐Hyun Jo, Sergio D. Rosenzweig, Michael C. Kelly, Heidi H. Kong, Keisuke Nagao and Seon‐Pil Jin and has published in prestigious journals such as Nature Medicine, The American Journal of Surgical Pathology and Leukemia.

In The Last Decade

Julie Alejo

5 papers receiving 187 citations

Peers

Julie Alejo
Julie Alejo
Citations per year, relative to Julie Alejo Julie Alejo (= 1×) peers Marianna Gnoato

Countries citing papers authored by Julie Alejo

Since Specialization
Citations

This map shows the geographic impact of Julie Alejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Alejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Alejo more than expected).

Fields of papers citing papers by Julie Alejo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Alejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Alejo. The network helps show where Julie Alejo may publish in the future.

Co-authorship network of co-authors of Julie Alejo

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Alejo. A scholar is included among the top collaborators of Julie Alejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Alejo. Julie Alejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Kovalovsky, Damián, Elisaveta Voynova, Christoph Rader, et al.. (2021). Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia. Leukemia. 35(9). 2581–2591. 21 indexed citations
2.
Francischetti, Ivo M.B., Julie Alejo, Theresa Davies‐Hill, et al.. (2021). Neutrophil and Eosinophil Extracellular Traps in Hodgkin Lymphoma. HemaSphere. 5(9). e633–e633. 13 indexed citations
3.
‍Kim, Do Young, Tetsuro Kobayashi, Benjamin Voisin, et al.. (2020). Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report. Nature Medicine. 26(2). 236–243. 118 indexed citations
4.
Kohorn, Isabelle Von, Sydney Stein, Marcos J. Ramos-Benítez, et al.. (2020). In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Journal of the Pediatric Infectious Diseases Society. 9(6). 769–771. 11 indexed citations
5.
Egan, Caoimhe, Camille Laurent, Julie Alejo, et al.. (2019). Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma. The American Journal of Surgical Pathology. 44(5). 657–664. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026